The Kansas City Chiefs are reportedly signing Nebraska safety DeShon Singleton as an undrafted rookie free-agent, per ESPN's Jeremy Fowler. DeShon Singleton is a long-limbed, heavy-tackling, box ...

For the first time, Pittsburgh Steelers safety DeShon Elliott opened up on his devastating season-ending knee injury that he suffered last season. Elliot told Cam Heyward that he thought it was a Nick ...

Tech That Scales: A Practical Framework for Artificial Intelligence–Enabled Cancer Care in Low- and Middle-Income Countries and Underserved US Counties Desmoid tumors (DTs) are rare fibroblastic ...

As is often the case for any team coming off a Super Bowl victory, the Seattle Seahawks saw several key players leave in free agency. Teams are always eager to add championship-caliber players to ...

INDIANAPOLIS — A pair of veteran Pittsburgh Steelers starters who finished this past season on the injured reserve list appear poised for full-go work by this summer. Safety DeShon Elliott and tight ...

Elliott (knee) recorded 38 total tackles (20 solo), including 1.0 sacks, while also adding two passes defensed, one of which was an interception, and a forced fumble over five games during the 2025 ...

Nebraska football had two representatives in the 2026 Senior Bowl as defensive backs DeShon Singleton and Ceyair Wright showcased their NFL draft potential. Nebraska football's defensive back alums ...

If the Pittsburgh Steelers are going to make a deep run in the playoffs, they need every healthy player they can get. One player this team could really use is starting strong safety DeShon Elliott.

Nebraska safety DeShon Singleton will not play in Wednesday’s Las Vegas Bowl due to a recent surgery. The team made this announcement on Monday afternoon. Singleton played a vital role in the Huskers' ...

LAS VEGAS, Nev. (WOWT) - Nebraska senior safety DeShon Singleton will miss the SRS Distribution Las Vegas Bowl with an injury, according to interim defensive coordinator Phil Snow. Singleton, who ...

Immunome’s investigational oral therapy has slashed the risk of disease progression or death by 84% for patients with desmoid tumors, data one analyst describes as a “near best-case outcome.” The ...